NasdaqGS:CERTHealthcare Services
What Certara (CERT)'s NVIDIA BioNeMo Partnership Means For Shareholders
In late June 2026, Certara announced a partnership with NVIDIA to integrate the BioNeMo Agent Toolkit into its AI-driven biosimulation and drug development platform, aiming to enhance tasks such as dose optimization and regulatory evidence preparation.
This collaboration links Certara’s established model-informed drug development expertise with frontier AI agents, potentially reshaping how pharmaceutical R&D teams conduct and scale computational biology workflows.
We’ll now examine how...